Capital Group Global Equity Fund (LUX) Z (CHF)Register to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 11.8 | 15.3 | -5.4 | 11.2 | 8.6 | |
+/-Cat | 1.2 | -2.7 | 4.0 | -1.6 | -1.2 | |
+/-B’mrk | -0.5 | -4.3 | 2.3 | -4.1 | -4.1 | |
Category: Global Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar Global TME NR USD |
Key Stats | ||
NAV 25/10/2024 | CHF 45.37 | |
Day Change | -0.34% | |
Morningstar Category™ | Global Large-Cap Blend Equity | |
ISIN | LU0817818262 | |
Fund Size (Mil) 25/10/2024 | USD 665.48 | |
Share Class Size (Mil) 25/10/2024 | EUR 101.45 | |
Max Initial Charge | 5.25% | |
Ongoing Charge 26/01/2024 | 0.90% |
Investment Objective: Capital Group Global Equity Fund (LUX) Z (CHF) |
Long-term capital growth through investment primarily in listed Equity, researched and selected on a world-wide basis. Unlisted securities may also be purchased, subject to the relevant provisions of the "General Investment Guidelines and Restrictions". |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Philip Winston 22/01/2020 | ||
William Robbins 22/01/2020 | ||
Click here to see others | ||
Inception Date 25/04/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR USD | Morningstar Global TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Capital Group Global Equity Fund (LUX) Z (CHF) | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Broadcom Inc | Technology | 2.75 |
Novo Nordisk AS Class B | Healthcare | 2.52 |
Microsoft Corp | Technology | 2.33 |
Apple Inc | Technology | 2.15 |
AstraZeneca PLC | Healthcare | 2.04 |
Increase Decrease New since last portfolio | ||
Capital Group Global Equity Fund (LUX) Z (CHF) |